Akshita Chawla

Statistics

Publications

Citations

1.7K

H-Index

Active since

2001

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Bristol

Public Health England

University of Oxford

St Thomas' Hospital

Akshita Chawla is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacokinetics, pharmacology, and infectious diseases.

ORCID

Publications per year

2001–2023

Publications

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

Victoria Hall, Sarah Foulkes, Ayoub Saei et al. · The Lancet · 2021 · 837 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Victoria Hall, Sarah Foulkes, André Charlett et al. · The Lancet · 2021 · 738 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Chronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination

Rajesh Krishna, Ferdous Gheyas, Yanhong Liu et al. · Clinical Pharmacology & Therapeutics · 2017 · 56 citations

Medicine, Pharmacokinetics, Pharmacology +13

Cryptic individual scaling relationships and the evolution of morphological scaling

Austin P. Dreyer, Omid Saleh Ziabari, Eli M. Swanson et al. · Evolution · 2016 · 27 citations

Life Sciences, Biology, Evolutionary Biology +16

Operating characteristics of stepwise covariate selection in pharmacometric modeling

Malidi Ahamadi, Anna Largajolli, Paul M. Diderichsen et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2019 · 27 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

1–5 of 7